U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in SwedenBengt Glimelius, Tobias Sjöblom, Beatrice Melin et al.|Acta Oncologica|2017Cited by 102
Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registryHjalmar Flygt, Johan Richter, Anna Lübking et al.|British Journal of Haematology|2021Cited by 15